Formulary Coverage of Brand-Name Adalimumab and Biosimilars Across Medicare Part D Plans.

Autor: Klebanoff MJ; Division of General Internal Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia.; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia., Li P; Division of General Internal Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia., Lin JK; The University of Texas MD Anderson Cancer Center, Houston., Doshi JA; Division of General Internal Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia.; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.
Jazyk: angličtina
Zdroj: JAMA [JAMA] 2024 Jul 02; Vol. 332 (1), pp. 74-76.
DOI: 10.1001/jama.2024.8917
Databáze: MEDLINE